725,000 doses of Covishield vaccine arrive

Nepal has received additional 725,000 doses of Covishield, the AstraZeneca type vaccine manufactured by the Serum institute of India, from the COVAX facility. It is a part of the 6 million doses of the vaccine committed to be provided through the COVAX facility supported by the United Nations. “We have received 725,550 doses of Covishield from COVAX facility,” said Upendra Dhungana, chief of Logistic Management Section under the Department of Health Services. The second consignment of the vaccine with 972,000 doses will arrive soon, added Dhungana.

सम्बन्धित सामग्री

Govt to give Covishield & AstraZeneca for first dose

Citizens who are to receive their first dose of COVID vaccine will only be vaccinated with Covishield and AstraZeneca.

3,072,278 doses of Vero Cell, Covishield vaccine arriving today

A total of 3,072,278 doses vaccine comprising 1,870,500 doses of Vero Cell and 1,201,778 doses of Covishield is arriving in Nepal today.

972,000 doses of Covishield vaccine arriving in Nepal today

KATHMANDU, Dec 1: As many as 972,000 doses of Covishield vaccine from the Serum Institute of India are set to arrive in Nepal today.

One million doses of Covishield vaccine from India by Saturday

One million doses of the Covishield vaccine purchased by Nepal from the government of India last February will be arriving by this Saturday.

AstraZeneca vaccine for people above 65 as second dose of Covishield

KATHMANDU, August 9: The Ministry of Health and Population has launched the AstraZeneca vaccination drive targeting the senior citizens above 65 years of age who have received the first dose of Covishield vaccine.  The two-day vaccination campaign kicked off today. According to Ministry's joint-spokesperson Dr Samir Kumar Adhikari, the campaign was launched following the arrival of AstraZeneca vaccines from Bhutan and Japan.  Covishield and AstraZeneca vaccine are developed by the same company and based on the same formula, with different brand names.  It makes no difference for those already getting the first jab of Covishield to receive the AstraZeneca as the second dose. Senior citizens receiving the first dose of Covishield are to get the second dose after around four and half months of receiving the first dose.  Some 1.4 million people above 65 years of age were given the first dose of Covishield from March 7 to 24.  The second dose was delayed as vaccine purchased from India was not supplied.  The vaccine is available from 149 vaccination centres in the capital.

AstraZeneca vaccine to be provided as alternative to Covishield

The government is to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of Covishield vaccine.

AstraZeneca vaccine to be administered as alternative to Covishield

KATHMANDU, June 7: The government is  preparing to administer the AstraZeneca COVID-19 vaccine as an alternative to the booster dose the Covishield vaccine. The government ‘s decision comes after the Serum Institute of India, the manufacturing company of Covishield vaccine and the COVAX Facility expressed inability to supply additional quantities of Covishield vaccines to Nepal for the time being.  The Ministry of Health and Population (MOHP) is planning to administer the AstraZeneca vaccine for those waiting for the booster shot of Covishield as both vaccines are similar in nature and composition. Director of Family Welfare Division, Department of Health Services, Dr Taranath Pokhrel said that  AstraZeneca will be provided  to those receiving the first jab of Covishield as both vaccines were developed by the same company being based on the same formula and methodology and it would make no difference in giving the AstraZeneca as an alternative to the Covishield. The vaccination schedule is yet to be fixed. The booster or second dose is to be taken after 12-16 weeks of getting the first shot.   \Around 1.4 million people above 65 years of age were provided the first shot of Covishield from 7th March to  23rd March.  They are waiting for the final shot as the Serum Institute of India expressed its inability to supply one million doses of vaccines that Nepal had procured from the company for the time being in view of the increasing infections rate in India.  So far in Nepal, the number of the population receiving the first shot of COVID-19 jab stands at 2.13 million while 691,184 have received the full course. The government is administering the China –manufactured Vero Cell to the people from 60-64 age group from tomorrow, Tuesday.

AstraZeneca vaccine to be provided as alternative to Covishield

KATHMANDU, June 7: The government has decided to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of the Covishield vaccine.

Administration of second shot of Covishield vaccine resumes from today

KATHMANDU, May 26: Those who were vaccinated against the coronavirus in the first phase of vaccination drive priority before March 7, but did not second jab owing to vaccine crunch, are being inoculated from Wednesday With the Health Office of Bagmati Province’s  Social Development Ministry, on Tuesday, deciding to continue the drive , the second dose will be administered to frontline workers including the health professionals, security personnel and sanitation staff.  According to the Lalitpur-based Health Office, only security personnel will be vaccinated for the second dose on Wednesday while health workers, government employees, sanitation staff, media persons, staff at diplomatic missions, public enterprises and financial institutions are scheduled to receive the second shot of the Covishield vaccine on Thursday and Friday.  One should visit the Jawalakhel-based Metropolitan Police Circle on Wednesday while the Health Office, Lalitpur has been designated as the vaccination center for Thursday onwards.  One is required to produce the vaccine card, which s/he had received during the first shot, and an identity card for the second shot, according to the office.